๐๐ฎ๐ฅ๐ฒ ๐๐๐ฐ๐ฌ ๐๐จ๐ฎ๐ง๐ ๐๐ฉ ๐ ๐๐๐ฎ๐ฌ๐๐ก & ๐๐จ๐ฆ๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฌ ๐๐ซ๐ฎ๐ค๐๐ซ๐...
๐๐ฌ๐ฌ๐ข๐ฅ๐จ๐ซ๐๐ฎ๐ฑ๐จ๐ญ๐ญ๐ข๐๐ ๐๐๐ช๐ฎ๐ข๐ซ๐๐ฌ 80% ๐๐ญ๐๐ค๐ ๐ข๐ง ๐๐๐ข๐๐๐ฅ๐๐๐ซ๐ ๐๐ง๐ ๐ข๐ง๐๐๐ซ๐ข๐ง๐
๐ค EssilorLuxottica has acquired an 80% stake in Heidelberg Engineering, a leader in optical coherence tomography (OCT), real-time image processing, analytics, and digital surgical navigation technologies. Despite the acquisition, Heidelberg Engineering will continue to operate independently under its brand.
๐ช Francesco Milleri, Chairman and CEO, and Paul du Saillant, Deputy CEO of EssilorLuxottica, highlighted the strategic fit of Heidelberg Engineeringโs expertise in early detection and diagnosis, which will strengthen EssilorLuxotticaโs presence in the med-tech sector.
๐
๐๐ ๐๐ฅ๐๐๐ซ๐ฌ ๐๐๐ข๐๐๐ฅ๐๐๐ซ๐ ๐๐ง๐ ๐ข๐ง๐๐๐ซ๐ข๐ง๐ โ๐ฌ ๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐ ๐๐จ๐๐ฎ๐ฅ๐ ๐ฐ๐ข๐ญ๐ก ๐๐๐๐
๐ ๐๐๐๐ก๐ง๐จ๐ฅ๐จ๐ ๐ฒ.
๐ Heidelberg Engineering has announced that the FDA has granted 510(k) clearance for its SPECTRALIS Optical Coherence Tomography-Angiography (OCTA) Module with SHIFT technology. This advances module is designed to significantly reduce image acquisition time, enhancing efficiency in clinical settings.
๐ฉโ๐ป The initial version of the SPECTRALIS OCTA Module received FDA clearance in September 2018. In March 2022, SHIFT technology was introduced, allowing clinicians to switch between three OCT scan speeds. The latest enhancement, integrating SHIFT technology, is reported to cut image acquisition time by 50% while maintaining a high lateral resolution of 5.7 ฮผm/pix.
๐ Heidelberg Engineering has equipped this module with a more powerful OCT engine, updated graphics processing technology, and optimized software, ensuring improved performance and image quality.
